Seamus Fernandez
Stock Analyst at Guggenheim
(4.90)
# 251
Out of 4,352 analysts
394
Total ratings
62%
Success rate
24.2%
Average return
Main Sectors:
Stocks Rated by Seamus Fernandez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IVA Inventiva | Reiterated: Buy | $11 | $4.93 | +123.12% | 6 | May 27, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintained: Buy | $35 | $21.46 | +63.09% | 13 | May 26, 2026 | |
| MLYS Mineralys Therapeutics | Maintained: Buy | $48 | $31.50 | +52.38% | 8 | May 18, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintained: Hold | n/a | $7.92 | - | 10 | May 11, 2026 | |
| ACRS Aclaris Therapeutics | Reiterated: Buy | $12 | $4.55 | +163.74% | 4 | May 11, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $143 | $88.32 | +61.91% | 12 | May 11, 2026 | |
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | $30 | $14.35 | +109.06% | 8 | May 11, 2026 | |
| MBX MBX Biosciences | Reiterated: Buy | $88 | $31.47 | +179.63% | 13 | May 8, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | $116 | $51.40 | +125.68% | 11 | May 7, 2026 | |
| GPCR Structure Therapeutics | Maintained: Buy | $140 | $39.34 | +255.87% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $72 | $57.18 | +25.92% | 46 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,163 → $1,183 | $1,105.00 | +7.06% | 61 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $25 | $7.29 | +242.94% | 4 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $82.14 | +94.79% | 11 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 16,000p → 16,500p | $13,802.00 | +19.55% | 18 | Mar 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $13.12 | +128.66% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $34 | $11.87 | +186.44% | 5 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $43.67 | - | 12 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €110.00 → €101.00 | $75.29 | +34.15% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $45.58 | n/a | 10 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.05 | n/a | 12 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 1,013 → kr 798.00 | $294.33 | n/a | 4 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.54 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,881.50 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $130 | $118.72 | n/a | 36 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $83 | $17.69 | n/a | 5 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.14 | n/a | 2 | Dec 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $130.85 | n/a | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $117.82 | n/a | 4 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $150.17 | n/a | 16 | Oct 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $6.04 | n/a | 1 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.93 | n/a | 2 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $26.18 | n/a | 16 | Sep 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 | $14.52 | n/a | 1 | Aug 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $6.93 | n/a | 3 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $301.98 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $336.79 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $614.78 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $225.33 | n/a | 2 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $29.40 | n/a | 5 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $31.43 | n/a | 1 | Mar 7, 2016 |
Inventiva
May 27, 2026
Reiterated: Buy
Price Target: $11
Current: $4.93
Upside: +123.12%
Arcutis Biotherapeutics
May 26, 2026
Maintained: Buy
Price Target: $35
Current: $21.46
Upside: +63.09%
Mineralys Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $48
Current: $31.50
Upside: +52.38%
Arcturus Therapeutics Holdings
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $7.92
Upside: -
Aclaris Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $12
Current: $4.55
Upside: +163.74%
Rhythm Pharmaceuticals
May 11, 2026
Reiterated: Buy
Price Target: $143
Current: $88.32
Upside: +61.91%
Amylyx Pharmaceuticals
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $14.35
Upside: +109.06%
MBX Biosciences
May 8, 2026
Reiterated: Buy
Price Target: $88
Current: $31.47
Upside: +179.63%
Vaxcyte
May 7, 2026
Reiterated: Buy
Price Target: $116
Current: $51.40
Upside: +125.68%
Structure Therapeutics
May 7, 2026
Maintained: Buy
Price Target: $140
Current: $39.34
Upside: +255.87%
May 6, 2026
Maintained: Buy
Price Target: $72
Current: $57.18
Upside: +25.92%
May 5, 2026
Maintained: Buy
Price Target: $1,163 → $1,183
Current: $1,105.00
Upside: +7.06%
Apr 29, 2026
Reiterated: Buy
Price Target: $27 → $25
Current: $7.29
Upside: +242.94%
Mar 30, 2026
Reiterated: Buy
Price Target: $160
Current: $82.14
Upside: +94.79%
Mar 29, 2026
Reiterated: Buy
Price Target: 16,000p → 16,500p
Current: $13,802.00
Upside: +19.55%
Mar 24, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $13.12
Upside: +128.66%
Mar 16, 2026
Maintained: Buy
Price Target: $25 → $34
Current: $11.87
Upside: +186.44%
Dec 9, 2025
Downgraded: Hold
Price Target: n/a
Current: $43.67
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: €110.00 → €101.00
Current: $75.29
Upside: +34.15%
Apr 17, 2025
Downgraded: Hold
Price Target: n/a
Current: $45.58
Upside: n/a
Apr 3, 2025
Rated: Hold
Price Target: n/a
Current: $3.05
Upside: n/a
Jan 17, 2025
Maintained: Buy
Price Target: kr 1,013 → kr 798.00
Current: $294.33
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $50.54
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $1,881.50
Upside: n/a
Jan 29, 2024
Maintained: Buy
Price Target: $125 → $130
Current: $118.72
Upside: n/a
Oct 14, 2022
Maintained: Buy
Price Target: $250 → $83
Current: $17.69
Upside: n/a
Dec 15, 2021
Downgraded: Hold
Price Target: n/a
Current: $1.14
Upside: n/a
Dec 7, 2021
Downgraded: Hold
Price Target: n/a
Current: $130.85
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: n/a
Current: $117.82
Upside: n/a
Oct 8, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $150.17
Upside: n/a
Oct 17, 2017
Initiated Coverage: Buy
Price Target: $13
Current: $6.04
Upside: n/a
Sep 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $4.93
Upside: n/a
Sep 8, 2016
Maintained: Hold
Price Target: $37
Current: $26.18
Upside: n/a
Aug 24, 2016
Reiterated: Buy
Price Target: $108
Current: $14.52
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $52
Current: $6.93
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $301.98
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $336.79
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $614.78
Upside: n/a
Jun 14, 2016
Maintained: Buy
Price Target: $125
Current: $225.33
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $56
Current: $29.40
Upside: n/a
Mar 7, 2016
Downgraded: Hold
Price Target: $4
Current: $31.43
Upside: n/a